Announcements
Sidley Represents Capricor Therapeutics in US$172.5 Million Common Stock Offering
December 10, 2025
Sidley represented Capricor Therapeutics, Inc. in connection with an underwritten public offering of 6,900,000 shares of its common stock, including the exercise in full of the underwriters’ option to purchase additional shares to cover over-allotments, bringing the total gross proceeds to Capricor from the offering to approximately US$172.5 million. Piper Sandler & Co. and Oppenheimer & Co. Inc. acted as the joint book-running managers for the offering and H.C. Wainwright & Co. acted as co-manager.
The deal team was led by Rob Carlson (M&A and Private Equity) and included Nick DeAngelis and John E. Walker (M&A and Private Equity).
Contacts
Capabilities
Suggested News & Insights
Sidley Shortlisted at the FT Innovative Lawyers Awards Europe 2026July 9, 2026Delaware Court of Chancery Draws a Line on Release Conditions in M&AJuly 8, 2026EU Forced Labor Regulation Moves Toward Implementation: How Companies Should PrepareJuly 7, 2026Sidley Represents Clara Vista Investment Partners in Its Acquisition of Majority Stake in Frosinone CalcioJuly 6, 2026Sidley Represents Olympus Power in Formation of Winslow Power Joint Venture and Acquisition of Generating AssetsJuly 6, 2026Sidley Adds Insurance M&A Partner Carl Hotton To Growing London OfficeJuly 2, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory